Evidence map›Paper›PMID 33889211›Full record

ArticleEcancermedicalscience2021

Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic.

Dorothy Lombe, Richard Sullivan, Carlo Caduff, Zipporah Ali, Nirmala Bhoo-Pathy, Jim Cleary, Matt Jalink, Tomohiro Matsuda, Deborah Mukherji, Diana Sarfati and 3 more

Abstract readCase Reports
In one paragraph

Article in Ecancermedicalscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Experiences of cancer care in COVID-19: A longitudinal qualitative study.European journal of oncology nursing : the official journal of European Oncology Nursing Society · 2022
    Article
  5. Article
  6. Review
  7. Experiences and coping strategies of women receiving treatment for breast and gynecological cancers during the COVID-19 pandemic: A qualitative study.European journal of oncology nursing : the official journal of European Oncology Nursing Society · 2021
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Dorothy LombeCancer Diseases Hospital, Lusaka, 10101, Zambia.
Richard SullivanInstitute of Cancer Policy, King's College London, London, WC2R 2LS, United Kingdom.
Carlo CaduffKing's College London, London, WC2R 2LS, United Kingdom.
Zipporah AliKenya Hospices and Palliative Care Association, Nairobi, 00202, Kenya.
Nirmala Bhoo-PathyDepartment of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, 50603, Malaysia.
Jim ClearyDepartment of Medicine and IU Simon Cancer Center, IU School of Medicine, Indianapolis, IN 46202, USA.
Matt JalinkDivision of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, K7L 3N6, Canada.
Tomohiro MatsudaPopulation-based Cancer Registry Section, Division of Surveillance, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, 104-0045, Japan.
Deborah MukherjiDepartment of Internal Medicine, Division of Hematology-Oncology, American University of Beirut Medical Center (AUBMC), Beirut, 1107 2020, Lebanon.
Diana SarfatiTe Aho o Te Kahu, Cancer Control Agency, Wellington, 6011, New Zealand.
Verna VanderpuyeNational Center for Oncology, Radiotherapy, and Nuclear Medicine, Accra, 00233, Ghana.
Aasim YusufShaukat Khanum Memorial Cancer Hospital and Research Centres, Lahore and Peshawar, 25100, Pakistan.
Christopher BoothDivision of Cancer Care and Epidemiology, Cancer Research Institute, Queen's University, Kingston, K7L 3N6, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPublic health emergencies and crises such as the current COVID-19 pandemic can accelerate innovation and place renewed focus on the value of health interventions. Capturing important lessons learnt, both positive and negative, is vital. We aimed to document the perceived positive changes (silver linings) in cancer care that emerged during the COVID-19 pandemic and identify challenges that may limit their long-term adoption.

methodsThis study employed a qualitative design. Semi-structured interviews (

resultsTen themes of positive changes were identified which included: value in cancer care, digital communication, convenience, inclusivity and cooperation, decentralisation of cancer care, acceleration of policy change, human interactions, hygiene practices, health awareness and promotion and systems improvement. Impediments to the scale-up of these positive changes included resource disparities and variation in legal frameworks across regions. Barriers were largely attributed to behaviours and attitudes of stakeholders.

conclusionThe COVID-19 pandemic has led to important value-based innovations and changes for better cancer care across different health systems. The challenges to maintaining/implementing these changes vary by setting. Efforts are needed to implement improved elements of care that evolved during the pandemic.

Indexed as

barrierscancer careCOVID-19policy changesilver linings

Identifiers

PMID33889211
PMCPMC8043681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.